Novartis Sues Bayer Over Hemophilia Drug Patent

Law360, New York (February 20, 2008, 12:00 AM EST) -- Swiss drugmaker Novartis AG has sued Bayer AG and its U.S. subsidiary for infringement over the German company's drug Kogenate, a medicine used to treat hemophilia.

Novartis' California-based vaccines and diagnostics division, Novartis Vaccines and Diagnostics Inc., and Danish drugmaker Novo Nordisk A/S filed the suit in the U.S District Court for the Eastern District of Texas on Friday. Also named in the suit is Pennsylvania-based CSL Behring, which makes the antihemophilic drug Helixate.

Novartis and Novo Nordisk are seeking treble damages in the suit, which...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.